Search Results - "Martin, Paul T"

Refine Results
  1. 1

    Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes by Cramer, Megan L., Xu, Rui, Martin, Paul T.

    Published in Molecular and cellular biology (01-07-2019)
    “…GALGT2 (also B4GALNT2) encodes a glycosyltransferase that is normally confined to the neuromuscular and myotendinous junction in adult skeletal muscle. GALGT2…”
    Get full text
    Journal Article
  2. 2

    Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State by Okerblom, Jonathan J, Schwarz, Flavio, Olson, Josh, Fletes, William, Ali, Syed Raza, Martin, Paul T, Glass, Christopher K, Nizet, Victor, Varki, Ajit

    Published in The Journal of immunology (1950) (15-03-2017)
    “…Humans and chimpanzees are more sensitive to endotoxin than are mice or monkeys, but any underlying differences in inflammatory physiology have not been fully…”
    Get full text
    Journal Article
  3. 3

    Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors by Haidet, Amanda M, Rizo, Liza, Handy, Chalonda, Umapathi, Priya, Eagle, Amy, Shilling, Chris, Boue, Daniel, Martin, Paul T, Sahenk, Zarife, Mendell, Jerry R, Kaspar, Brian K

    “…Increasing the size and strength of muscles represents a promising therapeutic strategy for musculoskeletal disorders, and interest has focused on myostatin, a…”
    Get full text
    Journal Article
  4. 4

    Micro-laminin gene therapy can function as an inhibitor of muscle disease in the dyW mouse model of MDC1A by Packer, Davin, Martin, Paul T.

    “…Gene replacement for laminin-α2-deficient congenital muscular dystrophy 1A (MDC1A) is currently not possible using a single adeno-associated virus (AAV) vector…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Therapeutic efficacy of rscAAVrh74.miniCMV.LIPA gene therapy in a mouse model of lysosomal acid lipase deficiency by Lam, Patricia, Ashbrook, Anna, Zygmunt, Deborah A., Yan, Cong, Du, Hong, Martin, Paul T.

    “…Lysosomal acid lipase deficiency (LAL-D) presents as one of two rare autosomal recessive diseases: Wolman disease (WD), a severe disorder presenting in infancy…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration by Marshall, Jamie L, Holmberg, Johan, Chou, Eric, Ocampo, Amber C, Oh, Jennifer, Lee, Joy, Peter, Angela K, Martin, Paul T, Crosbie-Watson, Rachelle H

    Published in The Journal of cell biology (25-06-2012)
    “…Utrophin is normally confined to the neuromuscular junction (NMJ) in adult muscle and partially compensates for the loss of dystrophin in mdx mice. We show…”
    Get full text
    Journal Article
  9. 9

    Expansion of B4GALT7 linkeropathy phenotype to include perinatal lethal skeletal dysplasia by Mihalic Mosher, Theresa, Zygmunt, Deborah A, Koboldt, Daniel C, Kelly, Benjamin J, Johnson, Lisa R, McKenna, David S, Hood, Benjamin C, Hickey, Scott E, White, Peter, Wilson, Richard K, Martin, Paul T, McBride, Kim L

    Published in European journal of human genetics : EJHG (01-10-2019)
    “…Proteoglycans have a core polypeptide connected to glycosaminoglycans (GAGs) via a common tetrasaccharide linker region. Defects in enzymes that synthesize the…”
    Get full text
    Journal Article
  10. 10

    Identification of new dystroglycan complexes in skeletal muscle by Johnson, Eric K, Li, Bin, Yoon, Jung Hae, Flanigan, Kevin M, Martin, Paul T, Ervasti, James, Montanaro, Federica

    Published in PloS one (08-08-2013)
    “…The dystroglycan complex contains the transmembrane protein β-dystroglycan and its interacting extracellular mucin-like protein α-dystroglycan. In skeletal…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice by Camboni, Marybeth, Hammond, Sue, Martin, Laura T, Martin, Paul T

    Published in The Journal of pathology (01-01-2012)
    “…We have previously reported that mice with muscular dystrophy, including mdx mice, develop embryonal rhabdomyosarcoma (eRMS) with a low incidence after 1 year…”
    Get full text
    Journal Article
  14. 14

    rAAVrh74.MCK.GALGT2 Demonstrates Safety and Widespread Muscle Glycosylation after Intravenous Delivery in C57BL/6J Mice by Zygmunt, Deborah A., Xu, Rui, Jia, Ying, Ashbrook, Anna, Menke, Chelsea, Shao, Guohong, Yoon, Jung Hae, Hamilton, Sonia, Pisharath, Harshan, Bolon, Brad, Martin, Paul T.

    “…rAAVrh74.MCK.GALGT2 is a surrogate gene therapy that inhibits muscular dystrophy in multiple animal models. Here, we report on a dose-response study of…”
    Get full text
    Journal Article
  15. 15

    A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle by Martin, Paul T, Golden, Bethannie, Okerblom, Jonathan, Camboni, Marybeth, Chandrasekharan, Kumaran, Xu, Rui, Varki, Ajit, Flanigan, Kevin M, Kornegay, Joe N

    Published in PloS one (05-02-2014)
    “…The expression of N-glycolylneuraminic acid (Neu5Gc) and the cytotoxic T cell (CT) carbohydrate can impact the severity of muscular dystrophy arising from the…”
    Get full text
    Journal Article
  16. 16

    The Dystroglycanopathies: The New Disorders of O-Linked Glycosylation by Martin, Paul T.

    Published in Seminars in pediatric neurology (01-09-2005)
    “…It has become clear in the past half decade that a number of forms of congenital muscular dystrophy are in fact congenital disorders of glycosylation. Genes…”
    Get full text
    Journal Article
  17. 17

    Role of extracellular matrix proteins and their receptors in the development of the vertebrate neuromuscular junction by Singhal, Neha, Martin, Paul T.

    Published in Developmental neurobiology (Hoboken, N.J.) (01-11-2011)
    “…The vertebrate neuromuscular junction (NMJ) remains the best‐studied model for understanding the mechanisms involved in synaptogenesis, due to its relatively…”
    Get full text
    Journal Article
  18. 18

    A lethal injection? by Arumugam, Deepak, Dr, Atherton, John J, PhD, Martin, Paul T, PhD

    Published in The Lancet (British edition) (04-02-2012)
    “…Procainamide, which is similar to procaine (webappendix), is an antiarrhythmic drug that causes sodium channel blockade and should be avoided in patients with…”
    Get full text
    Journal Article
  19. 19

    Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease by Camboni, Marybeth, Wang, Chiou-Miin, Miranda, Carlos, Yoon, Jung Hae, Xu, Rui, Zygmunt, Deborah, Kaspar, Brian K, Martin, Paul T

    Published in Neurobiology of disease (01-02-2014)
    “…Abstract Recent clinical and pre-clinical studies suggest that both active and passive immunization strategies targeting Aβ amyloid may have clinical benefit…”
    Get full text
    Journal Article
  20. 20

    rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart by Xu, Rui, Jia, Ying, Zygmunt, Deborah A., Martin, Paul T.

    Published in Molecular therapy (06-03-2019)
    “…Dilated cardiomyopathy is a common cause of death in patients with Duchenne muscular dystrophy (DMD). Gene therapies for DMD must, therefore, have a…”
    Get full text
    Journal Article